ELISABETH OKROI: Open Payments
NPI 1356865414 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 26 payments from 10 companies in 2025. Trend: 2023 $639 · 2024 $871 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| COLOPLAST CORP | 4 | $213 |
| Medtronic, Inc. | 6 | $178 |
| Boston Scientific Corporation | 1 | $113 |
| Ferring Pharmaceuticals Inc. | 4 | $95 |
| Teleflex LLC | 3 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| UROGEN PHARMA, INC. | 2 | $55 |
| 180 Medical, Inc. | 1 | $51 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $25 |
| Telix Pharmaceuticals | 1 | $25 |
Products named: Luja Coude, INTERSTIM, General - Kidney Stone Disease, ADSTILADRIN, GEMTESA, ZUSDURI, UROLIFT, PYLARIFY.
Industry payments across OK — which companies pay providers there.
